memantine has been researched along with Anterior Circulation Transient Ischemic Attack in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Memantine treatment (n=9) reduced the brain water content significantly in the cortex compared to saline treatment (n=8; 83." | 5.30 | Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats. ( Dempsey, RJ; Dogan, A; Eras, MA; Rao, VL, 1999) |
| "We treated rats with transient cerebral ischemia with oligomeric forms of Abeta (Abeta oligomers), including dimers, trimers, and tetramers, intracerebroventricularly." | 1.36 | Dynamin 1 depletion and memory deficits in rats treated with Abeta and cerebral ischemia. ( Fujino, M; Fujiwara, M; Ii, M; Iwasaki, K; Katsurabayashi, S; Mishima, K; Nogami, A; Takasaki, K; Watanabe, T; Yamagata, N, 2010) |
| " The noncompetitive antagonist MK-801 and a glycine-site blocker were equally neuroprotective in both normal and reduced conditions, but there was a significant rightward shift in the dose-response curves of the competitive antagonists APV and CPP and the uncompetitive antagonist memantine." | 1.31 | Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro. ( Eshak, M; Iannotti, F; Pringle, AK; Self, J, 2000) |
| "Memantine treatment (n=9) reduced the brain water content significantly in the cortex compared to saline treatment (n=8; 83." | 1.30 | Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats. ( Dempsey, RJ; Dogan, A; Eras, MA; Rao, VL, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanashyan, MM | 1 |
| Shabalina, AA | 1 |
| Gnedovskaya, EV | 1 |
| Gan'shina, TS | 1 |
| Kurza, EV | 1 |
| Maslennikov, DV | 1 |
| Mirzoyan, RS | 1 |
| Watanabe, T | 1 |
| Iwasaki, K | 1 |
| Takasaki, K | 1 |
| Yamagata, N | 1 |
| Fujino, M | 1 |
| Nogami, A | 1 |
| Ii, M | 1 |
| Katsurabayashi, S | 1 |
| Mishima, K | 1 |
| Fujiwara, M | 1 |
| Bute, J | 1 |
| Waller, D | 1 |
| Cho, GS | 1 |
| Lee, JC | 1 |
| Ju, C | 1 |
| Kim, C | 1 |
| Kim, WK | 1 |
| Dogan, A | 1 |
| Eras, MA | 1 |
| Rao, VL | 1 |
| Dempsey, RJ | 1 |
| Pringle, AK | 1 |
| Self, J | 1 |
| Eshak, M | 1 |
| Iannotti, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Memantine for Enhanced Stroke Recovery[NCT02144584] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2014-01-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for memantine and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
[ANTIPLATELET AND ANTI-ISCHEMIC EFFECTS OF MEMANTINE AND 5-HYDROXYADAMANTAN-2-ONE IN PATIENTS WITH CEREBROVASCULAR PATHOLOGY AND IN EXPERIMENTS].
Topics: Adamantane; Adenosine Diphosphate; Aged; Animals; Animals, Outbred Strains; Blood Platelets; Cells, | 2016 |
Dynamin 1 depletion and memory deficits in rats treated with Abeta and cerebral ischemia.
Topics: Amyloid beta-Peptides; Animals; Dynamin I; Excitatory Amino Acid Antagonists; Hippocampus; Ischemic | 2010 |
Dementia with cardiac problems.
Topics: Adaptation, Psychological; Alzheimer Disease; Anecdotes as Topic; Arrhythmias, Cardiac; Dopamine Age | 2011 |
N-Methyl-D-aspartate receptor antagonists memantine and MK-801 attenuate the cerebral infarct accelerated by intracorpus callosum injection of lipopolysaccharides.
Topics: Animals; Anti-Inflammatory Agents; Cerebral Infarction; Corpus Callosum; Dizocilpine Maleate; Drug S | 2013 |
Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats.
Topics: Animals; Brain; Edema; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Male; Memantin | 1999 |
Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dithionitrobenzoic Acid; Dithiothreitol; Dizocilpine Maleate; | 2000 |